These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 8391925)
21. Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer. Põld M; Krysan K; Põld A; Dohadwala M; Heuze-Vourc'h N; Mao JT; Riedl KL; Sharma S; Dubinett SM Cancer Res; 2004 Sep; 64(18):6549-55. PubMed ID: 15374967 [TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-I inhibits the progression of human U-2 OS osteosarcoma cells towards programmed cell death through interaction with the IGF-I receptor. Herzlieb N; Gallaher BW; Berthold A; Hille R; Kiess W Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):71-7. PubMed ID: 10726973 [TBL] [Abstract][Full Text] [Related]
23. Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells. Krystal GW; Honsawek S; Kiewlich D; Liang C; Vasile S; Sun L; McMahon G; Lipson KE Cancer Res; 2001 May; 61(9):3660-8. PubMed ID: 11325836 [TBL] [Abstract][Full Text] [Related]
25. Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines. Favoni RE; de Cupis A; Ravera F; Cantoni C; Pirani P; Ardizzoni A; Noonan D; Biassoni R Int J Cancer; 1994 Mar; 56(6):858-66. PubMed ID: 7509779 [TBL] [Abstract][Full Text] [Related]
26. Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma. Szereday Z; Schally AV; Varga JL; Kanashiro CA; Hebert F; Armatis P; Groot K; Szepeshazi K; Halmos G; Busto R Cancer Res; 2003 Nov; 63(22):7913-9. PubMed ID: 14633721 [TBL] [Abstract][Full Text] [Related]
27. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306 [TBL] [Abstract][Full Text] [Related]
28. Effects of extracellular calcium on insulin-like growth factor II in human bone cells. Honda Y; Fitzsimmons RJ; Baylink DJ; Mohan S J Bone Miner Res; 1995 Nov; 10(11):1660-5. PubMed ID: 8592942 [TBL] [Abstract][Full Text] [Related]
29. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. Huynh H; Chow PK; Ooi LL; Soo KC Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812 [TBL] [Abstract][Full Text] [Related]
30. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells. Ghahary A; Tredget EE; Mi L; Yang L Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576 [TBL] [Abstract][Full Text] [Related]
31. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt. Yeh J; Litz J; Hauck P; Ludwig DL; Krystal GW Lung Cancer; 2008 May; 60(2):166-74. PubMed ID: 18006183 [TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, Annexin-V binding, and DNA-fragmentation in human MG63 osteosarcoma cells: co-activation of pro- and anti-apoptotic pathways by IGF-I. Raile K; Hille R; Laue S; Schulz A; Pfeifer G; Horn F; Kiess W Horm Metab Res; 2003; 35(11-12):786-93. PubMed ID: 14710359 [TBL] [Abstract][Full Text] [Related]
33. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor. Ambrose D; Resnicoff M; Coppola D; Sell C; Miura M; Jameson S; Baserga R; Rubin R J Cell Physiol; 1994 Apr; 159(1):92-100. PubMed ID: 8138595 [TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor. Pavelić K; Pavelić ZP; Cabrijan T; Karner I; Samarzija M; Stambrook PJ J Pathol; 1999 May; 188(1):69-75. PubMed ID: 10398143 [TBL] [Abstract][Full Text] [Related]
35. Influence of age and fetal hypophysectomy on porcine preadipocytes: insulin-like growth factor-I (IGF-I) response, receptor binding and IGF binding proteins secretion. Chen NX; Hausman GJ; Wright JT Growth Dev Aging; 1995; 59(4):193-206. PubMed ID: 8770611 [TBL] [Abstract][Full Text] [Related]
36. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer. Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452 [TBL] [Abstract][Full Text] [Related]
37. Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor. Long L; Rubin R; Brodt P Exp Cell Res; 1998 Jan; 238(1):116-21. PubMed ID: 9457063 [TBL] [Abstract][Full Text] [Related]
38. Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Kappel CC; Velez-Yanguas MC; Hirschfeld S; Helman LJ Cancer Res; 1994 May; 54(10):2803-7. PubMed ID: 8168113 [TBL] [Abstract][Full Text] [Related]
39. Characterization of insulin-like growth factor II receptors in human small cell lung cancer cell lines. Schardt C; Rotsch M; Erbil C; Göke R; Richter G; Havemann K Exp Cell Res; 1993 Jan; 204(1):22-9. PubMed ID: 8380141 [TBL] [Abstract][Full Text] [Related]
40. Differential effects of glucocorticoids on insulin-like growth factor I action in cultured human fibroblasts. Conover CA; Hintz RL; Johnson BF J Cell Physiol; 1995 Jun; 163(3):615-22. PubMed ID: 7775603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]